BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Amyloid plaques recast as cause of neural network dysfunction
Researchers have identified a link between amyloid plaques and dysfunctional neuronal conduction in animal models of Alzheimer’s disease (AD). Their study, which was...

More in BioWorld

BioWorld MedTech

Surgibox wins CE mark, humanitarian use nod for OR in a backpack
Surgibox Inc. won a CE mark for two components of its Surgifield system, an ultraportable sterile system that enables safe surgery any place, any time. The five-year-old...

More in BioWorld MedTech

BioWorld Science

Leukemia-related rogue immune cells cause autoimmune disorders
Does cancer cause autoimmune disease or is it the other way around? In looking at the question of which comes first, the chicken or the egg, researchers at the Garvan...

More in BioWorld Science

BioWorld Asia

Two deaths reported ahead of Eisai-Biogen’s presentation of phase III data on Alzheimer’s drug lecanemab
The shadow of two reported patients’ deaths hovers over Eisai Co Ltd. and Biogen Inc.’s Alzheimer’s disease treatment, lecanemab, as the companies prepare to present phase...

More in BioWorld Asia

BioWorld Insider Podcast

BioWorld staff writer Lee Landenberger talks with James Lanthier, the CEO of Mindset Pharma, which is developing what it calls “next-generation” psychedelic medicines to treat neurological and psychiatric disorders.